TimothyLeeMccavitMD

Pediatric Hematology & Oncology • Fort Worth, TX

Assistant Professor, Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Mccavit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mccavit's full profile

Already have an account?

Office
1500 Cooper St
Fort Worth, TX 76104
Phone+1 682-885-4007

Fax+1 682-885-4004

Education & Training

University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Texas Southwestern Medical CenterResidency, Pediatrics, 2002 - 2005
University of Texas Southwestern Medical SchoolClass of 2002

Certifications & Licensure

TX State Medical License 2004 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Completed
Phase 1, Phase 2
Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia Start of enrollment: 2013 Jul 01
Completed
Phase 4

Publications & Presentations

PubMed

630 citations
Improved survival of children and adolescents with sickle cell disease
Charles T. Quinn, Zora R. Rogers, Timothy L. McCavit, George R. Buchanan
Blood. 2008-11-16
51 citations
Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron
Jacquelyn M. Powers, Mark Shamoun, Timothy L. McCavit, Leah Adix, George R. Buchanan
The Journal of Pediatrics. 2017-01-01
5 citations
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)
Omar Niss, Robert B. Lorsbach, Mikaela Berger, Satheesh Chonat, Morgan L. McLemore
Blood Cells, Molecules & Diseases. 2021-03-01

Abstracts/Posters

Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
Timothy McCavit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Researchers Identify Best Treatment for Iron Deficiency Anemia in ChildrenJune 14th, 2017

Professional Memberships

American Academy of Pediatrics - AAP
Fellow